| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Feb, 2026 |
| Sales | 24,980 | 33,670 | 37,620 | 12,420 | 0 |
| Sales Growth | -25.81% | -10.50% | +202.90% | unch | unch |
| Net Income | -181,560 | -146,850 | -67,700 | -28,610 | 0 |
| Net Income Growth | -23.64% | -116.91% | -136.63% | unch | unch |
Exscientia Ltd ADR
(EXAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.
Fiscal Year End Date: 12/31